Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hasenclever

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
JAMA Oncology|January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical TrialStephen Daw, Alexander Claviez, Lars Kurch, et al.
JAMA Cardiology|September 20, 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical TrialJean-Luc Balligand, Dulce Brito, Oana Brosteanu, et al.
Pediatric Blood & Cancer|May 27, 2023
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphomaFriedrich Christian Franke, Adrian Damek, Jonas Steglich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
European Heart Journal|August 11, 2012
Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial--the RIPHeart-StudyPatrick Meybohm, Kai Zacharowski, Jochen Cremer, et al.
Blood|April 14, 2011
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adultsItziar Salaverria, Claudia Philipp, Ilske Oschlies, et al.
Scientific Reports|June 25, 2024
Hodgkin lymphoma: hypodense lesions in mediastinal massesAdrian Damek, Lars Kurch, Friedrich Christian Franke, et al.
Haematologica|August 8, 2024
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III studyDietger Niederwieser, Dirk Hasenclever, Wolfgang E Berdel, et al.
The New England Journal of Medicine|October 6, 2015
A Multicenter Trial of Remote Ischemic Preconditioning for Heart SurgeryPatrick Meybohm, Berthold Bein, Oana Brosteanu, et al.
The Lancet. Oncology|March 1, 2023
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration studyChristine Mauz-Körholz, Judith Landman-Parker, Ana Fernández-Teijeiro, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
JAMA Oncology|January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical TrialStephen Daw, Alexander Claviez, Lars Kurch, et al.
JAMA Cardiology|September 20, 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical TrialJean-Luc Balligand, Dulce Brito, Oana Brosteanu, et al.
Pediatric Blood & Cancer|May 27, 2023
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphomaFriedrich Christian Franke, Adrian Damek, Jonas Steglich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
European Heart Journal|August 11, 2012
Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial--the RIPHeart-StudyPatrick Meybohm, Kai Zacharowski, Jochen Cremer, et al.
Blood|April 14, 2011
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adultsItziar Salaverria, Claudia Philipp, Ilske Oschlies, et al.
Scientific Reports|June 25, 2024
Hodgkin lymphoma: hypodense lesions in mediastinal massesAdrian Damek, Lars Kurch, Friedrich Christian Franke, et al.
Haematologica|August 8, 2024
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III studyDietger Niederwieser, Dirk Hasenclever, Wolfgang E Berdel, et al.
The New England Journal of Medicine|October 6, 2015
A Multicenter Trial of Remote Ischemic Preconditioning for Heart SurgeryPatrick Meybohm, Berthold Bein, Oana Brosteanu, et al.
The Lancet. Oncology|March 1, 2023
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration studyChristine Mauz-Körholz, Judith Landman-Parker, Ana Fernández-Teijeiro, et al.
Pageof 10